Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

FRANCESCO TOVOLI

Assistant Professor

University of Bologna

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Pharmacotherapy

70%

Internal Medicine

80%

Liver Fibrosis

80%

Oncology

70%

Hepatology

60%

Cancer Therapy

50%

Targeted Therapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles23

TIMING THE SCAN: OPTIMIZING SCREENING FOR OSTEOPOROSIS AND RISK OF FRACTURE IN CELIAC DISEASE

Article Link

Year:

2025

Occupational toxicants in MASLD: Bias, complexity, and future directions

Article Link

Year:

2025

Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma

Article Link

Year:

2025

Advancements in immunotherapy for hepatocellular carcinoma

Article Link

Year:

2025

Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma

Article Link

Year:

2024

Exploring Total Immunoglobulin A’s Impact on Non-Biopsy Diagnosis of Celiac Disease: Implications for Diagnostic Accuracy

Article Link

Year:

2024

RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives

Article Link

Year:

2024

Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib

Article Link

Year:

2024

Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study

Article Link

Year:

2024

Autoimmune Polyendocrine Syndromes in Adult Italian Celiac Disease Patients

Article Link

Year:

2024

Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy

Article Link

Year:

2024

Evolution of bone densitometry parameters and risk of fracture in coeliac disease: a 10-year perspective

Article Link

Year:

2023

Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

Article Link

Year:

2023

TKIs in combination with immunotherapy for hepatocellular carcinoma

Article Link

Year:

2023

Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma

Article Link

Year:

2023

Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis

Article Link

Year:

2023

A Case of Advanced Hepatocellular Carcinoma with Bone Metastases Managed with Tyrosine Kinase Inhibitors and Aggressive Palliative Radiation Therapy: Role of Combination Therapy for Extending Survival

Article Link

Year:

2023

COVID-19: Has the Liver Been Spared?

Article Link

Year:

2023

Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study

Article Link

Year:

2023

Genetic, Immunological, Dietary, Gut Microbiota, and Environmental Determinants of Osteoporosis in the Course of Celiac Disease: Which Factor Plays the First Violin in This Orchestra?

Article Link

Year:

2023

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?

Article Link

Year:

2023

Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact

Article Link

Year:

2022

Does aspirin use influence hepatocellular carcinoma and cholangiocarcinoma prognosis?

Article Link

Year:

2022

Collaborators14

Ryszard Slomski

Institute of Human Genetics

POLAND

Agnieszka Dobrowolska

Poznan University of Medical Sciences

POLAND

Matteo Renzulli

University of Bologna

ITALY

Carlos López López

Universidad de Cantabria

SPAIN

MARIA LETIZIA PETRONI

Associate Professor

University of Bologna

ITALY

RICCARDO ANTONIO LENCIONI

University of Pisa

ITALY

Emilio Francesco Giunta

Università degli Studi della Campania Luigi Vanvitelli

ITALY

Fabio Gelsomino

ITALY

Franco Trevisani

University of Bologna

ITALY

Fabio Piscaglia

University of Bologna

ITALY

Laura Gramantieri

University of Bologna

ITALY

Anna Maria Rychter

Poznan University of Medical Sciences

POLAND

Caterina Soldà

Istituto Oncologico Veneto

ITALY

Francesca Fornari

University of Bologna

ITALY

How do I reach out?

Meet Kite AI